Tower Research Capital LLC (TRC) - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 70 filers reported holding TRINITY BIOTECH PLC in Q3 2013. The put-call ratio across all filers is 0.06 and the average weighting 0.4%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q3 2019$0
-100.0%
136
-90.8%
0.00%
Q2 2019$2,000
-94.9%
1,477
-89.3%
0.00%
-100.0%
Q1 2019$39,000
+44.4%
13,853
+17.9%
0.00%0.0%
Q4 2018$27,000
-54.2%
11,753
-19.7%
0.00%
-50.0%
Q3 2018$59,000
+28.3%
14,641
+60.2%
0.00%
+33.3%
Q2 2018$46,000
-9.8%
9,140
-8.0%
0.00%
-25.0%
Q1 2018$51,000
+10.9%
9,936
+9.2%
0.00%
-33.3%
Q4 2017$46,000
-33.3%
9,096
-26.1%
0.01%0.0%
Q3 2017$69,000
+430.8%
12,308
+475.4%
0.01%
+500.0%
Q2 2017$13,000
+1200.0%
2,139
+1143.6%
0.00%
Q1 2017$1,000
-50.0%
172
-50.0%
0.00%
Q4 2016$2,000
-92.3%
344
-82.7%
0.00%
-100.0%
Q3 2016$26,000
+766.7%
1,994
+564.7%
0.00%
Q2 2016$3,000
-81.2%
300
-77.7%
0.00%
-100.0%
Q1 2016$16,000
+700.0%
1,346
+573.0%
0.00%
Q4 2015$2,000
+100.0%
200
+138.1%
0.00%
Q3 2015$1,000
-98.7%
84
-98.0%
0.00%
-100.0%
Q2 2015$75,000
+1775.0%
4,141
+1939.9%
0.01%
Q3 2014$4,000
-95.4%
203
-94.6%
0.00%
-100.0%
Q2 2014$87,000
+128.9%
3,763
+151.5%
0.01%
+83.3%
Q4 2013$38,000
+442.9%
1,496
+349.2%
0.01%
+500.0%
Q3 2013$7,000
-30.0%
333
-42.2%
0.00%0.0%
Q2 2013$10,0005760.00%
Other shareholders
TRINITY BIOTECH PLC shareholders Q3 2013
NameSharesValueWeighting ↓
Lyon Street Capital, LLC 739,669$13,514,0006.33%
ACK Asset Management 749,867$13,700,0004.92%
CASTLEROCK ASSET MANAGEMENT INC 26,751$489,0004.12%
GOLDMAN CAPITAL MANAGEMENT INC 309,297$5,651,0002.83%
Paradice Investment Management LLC 348,686$6,370,0001.66%
Park West Asset Management LLC 600,770$10,976,0001.62%
Adirondack Research & Management Inc. 220,638$4,031,0001.50%
RK Capital 375,043$6,852,0001.40%
KEANE CAPITAL MANAGEMENT INC 70,000$1,279,0001.23%
CARDINAL CAPITAL MANAGEMENT LLC /CT 953,618$17,423,0001.08%
View complete list of TRINITY BIOTECH PLC shareholders